AHCO (AdaptHealth) Debt-to-Equity : 1.44 (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is AdaptHealth Debt-to-Equity?

AdaptHealth's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $59 Mil. AdaptHealth's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $2,120 Mil. AdaptHealth's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $1,516 Mil. AdaptHealth's debt to equity for the quarter that ended in Sep. 2024 was 1.44.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for AdaptHealth's Debt-to-Equity or its related term are showing as below:

AHCO' s Debt-to-Equity Range Over the Past 10 Years
Min: -45.67 Med: 1.15 Max: 55.12
Current: 1.44

During the past 7 years, the highest Debt-to-Equity Ratio of AdaptHealth was 55.12. The lowest was -45.67. And the median was 1.15.

AHCO's Debt-to-Equity is ranked worse than
91.62% of 704 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs AHCO: 1.44

AdaptHealth Debt-to-Equity Historical Data

The historical data trend for AdaptHealth's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AdaptHealth Debt-to-Equity Chart

AdaptHealth Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-10.73

2.27

1.15

1.08

1.57

AdaptHealth Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															1.33	1.57	1.60	1.50	1.44

Competitive Comparison of AdaptHealth's Debt-to-Equity

For the Medical Devices subindustry, AdaptHealth's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AdaptHealth's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AdaptHealth's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where AdaptHealth's Debt-to-Equity falls into.

AdaptHealth Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

AdaptHealth's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(91.76	+	2202.889)	/	1458.454
	=	1.57

AdaptHealth's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(58.833	+	2119.877)	/	1516.256
	=	1.44

AdaptHealth (NAS:AHCO) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

AdaptHealth Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of AdaptHealth's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AdaptHealth Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AdaptHealth Corp (NAS:AHCO) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

220 West Germantown Pike, Suite 250, Plymouth Meeting, PA, USA, 19462

Website

https://www.adapthealth.com

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Executives

Dale B Wolf	director
Shaw Rietkerk	officer: Chief Revenue Officer	C/O ADAPTHEALTH LLC, 220 WEST GERMANTOWN PIKE, SUITE 250, PLYMOUTH MEETING PA 19462
Williams David Solomon Iii	director	6272 CONDON AVE, LOS ANGELES CA 90056
James E Flynn	director, 10 percent owner, other: Director by Deputization	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Albert A. Prast	officer: Chief Technology Officer	3325 BARTLETT BLVD., ORLANDO FL 32811
Skyknight Aero Holdings, Llc	director	C/O SKYKNIGHT CAPITAL, L.P., ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129
Jason A Clemens	officer: Chief Financial Officer	220 WEST GERMANTOWN PIKE, SUITE 250, C/O ADAPTHEALTH LLC, PLYMOUTH MEETING PA 19462
Christine E. Archbold	officer: Chief Accounting Officer	FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ
Everest Hill Group Inc.	10 percent owner	TROPIC ISLE BUILDING, P O BOX 3331, ROAD TOWN TORTOLA D8 VG 1110
Daniel Bunting	officer: COO - Branch Operations	12200 N.W. AMBASSADOR DRIVE, SUITE 326, KANSAS CITY MO 64163
Christopher J Joyce	officer: General Counsel	C/O ALLIANCE ENTERTAINMENT CORP, 110 EAST 59TH STREET 18TH FLOOR, NEW YORK NY 10022
Skyknight Aero Holdings Ii, Llc	director	C/O SKYKNIGHT CAPITAL, L.P., ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129
Skyknight Capital, L.p.	director	C/O SKYKNIGHT CAPITAL, ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129
Skyknight Capital Fund Ii, L.p.	director	ONE LETTERMAN DRIVE, BUILDING C, SUITE 3-950, SAN FRANCISCO CA 94129
Stephen P Griggs	director, officer: Co-Chief Executive Officer	1360 PLACE VENDOME, WINTER PARK FL 32789